In the competitive landscape of pharmaceutical ingredients, Piroxicambeta-Cyclodextrin emerges as a highly valuable compound, offering significant advantages over conventional Piroxicam. This article provides a comprehensive overview of its properties, the benefits it confers on pharmaceutical formulations, and insights into its market availability.

Piroxicambeta-Cyclodextrin, bearing the CAS number 121696-62-6, is characterized by its physical appearance as a pale yellow powder. Its chemical composition, a complex of Piroxicam with beta-cyclodextrin, is meticulously prepared to achieve a high purity standard, typically 99.5% minimum assay. This stringent quality control ensures its suitability for pharmaceutical applications, where consistency and reliability are paramount.

The primary benefits of Piroxicambeta-Cyclodextrin stem from its ability to improve the pharmacokinetic profile of Piroxicam. Its enhanced water solubility leads to a faster absorption rate, which can expedite the onset of analgesic and anti-inflammatory effects. Moreover, the complexation significantly reduces the gastrointestinal irritation often associated with Piroxicam. This improved tolerability is a critical factor for patient compliance, especially in managing chronic pain and inflammatory conditions.

The market availability of high-quality Piroxicambeta-Cyclodextrin from trusted manufacturers, such as NINGBO INNO PHARMCHEM CO.,LTD., ensures that pharmaceutical companies have access to a reliable supply chain. The ability to purchase this compound online, with support for sample acquisition, further streamlines the drug development process. As the pharmaceutical industry continues to seek innovative solutions for drug delivery, Piroxicambeta-Cyclodextrin represents a key ingredient for developing advanced therapeutic products that offer improved efficacy and patient safety.